Low serum adiponectin levels in korean children with a family history of type 2 diabetes mellitus

Hormone Research in Paediatrics

Volumn 77, Issue 6, 2012, Pages 382-387

  Oh, Yeon Joung ^a   Nam, Hyo Kyoung ^b   Rhie, Young Jun ^b   Park, Sang Hee ^b   Lee, Kee Hyoung ^b  

^a Sahmyook Medical Center   (South Korea)

^b Korea University College of Medicine   (South Korea)

Author keywords

Adiponectin; Family history of type 2 diabetes mellitus; Korean children

Indexed keywords

ADIPONECTIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADOLESCENT; ANTHROPOMETRY; ARTICLE; CHILD; CHOLESTEROL BLOOD LEVEL; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; KOREA; MAJOR CLINICAL STUDY; MALE; MATSUDA INDEX; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; SCHOOL CHILD;

ADIPONECTIN; ADOLESCENT; ASIAN CONTINENTAL ANCESTRY GROUP; BODY MASS INDEX; CHILD; DIABETES MELLITUS, TYPE 2; FAMILY HEALTH; FEMALE; GLUCOSE INTOLERANCE; HUMANS; INSULIN RESISTANCE; MALE; OBESITY; REPUBLIC OF KOREA;

EID: 84863535505     PISSN: 16632818     EISSN: 16632826     Source Type: Journal    
DOI: 10.1159/000339154     Document Type: Article

References (38)

1. WHO: Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 2000; 894: 1-253.
2. Cook S, Weitzman M, Auinger P, Nguyen M, Dietz WH: Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition examination Survey, 1988-1994. Arch Pediatr Adolesc Med 2003; 157: 821-827. (Pubitemid 36988016)
3. Rosenbaum M, Nonas C, Horlick M, Fennoy I, Vargas I, Schachner H, Kringas P, Stanton K, Weil R: Beta-cell function and insulin sensitivity in early adolescence: association with body fitness and family history of type 2 diabetes mellitus. J Clin Endocrinol Metab 2004; 89: 5469-5476. (Pubitemid 39523131)
4. Park YS, Lee DH, Choi JM, Kang YJ, Kim CH: Trend of obesity in school age children in Seoul over the past 23 years. Korean J Pediatr 2004; 47: 247-257.
5. Kaufman FR: Type 2 diabetes in children and youth: a new epidemic. J Pediatr Endocrinol Metab 2002; 15: 737-744. (Pubitemid 34700348)
6. Arslanian SA: Type 2 diabetes mellitus in children: pathophysiology and risk factors. J Pediatr Endocrinol Metab 2000; 13(suppl 6):1385-1394. (Pubitemid 32061571)
7. American Diabetes Association: Type 2 diabetes in children and adolescents. Diabetes Care 2000; 23: 381-389.
8. da Silva RC, Miranda WL, Chacra AR, Dib SA: Insulin resistance,-cell function, and glucose tolerance in Brazilian adolescents with obesity or risk factors for type 2 diabetes mellitus. J Diab Complications 2007; 21: 84-92. (Pubitemid 46321520)
9. Sathanur RS, Maria GF, Gerald SB: Longitudinal change in risk variables of insulin resistance syndrome from childhood to young adulthood in offspring of parents with type 2 diabetes: the Bogalusa Heart Study. Metabolism 2003; 52: 443-450; discussion 451-453.
10. Goran MI, Bergman RN, Avila Q, Watkins M, Ball GD, Shaibi GQ, Weigensberg MJ, Cruz ML: Impaired glucose tolerance and reduced beta-cell function in overweight Latino children with a positive family history for type 2 diabetes. J Clin Endocrinol Metab 2004; 89: 207-212. (Pubitemid 38183883)
11. Wonh GW, Wang J, Hug C, Tsao TS, Lodish HF: A family of Acrp30/adiponectin structural and functional paralogs. Proc Natl Acad Sci USA 2004; 101: 10302-10307. (Pubitemid 38924920)
12. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, Tataranni PA: Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001; 86: 1930-1935. (Pubitemid 32472900)
13. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K, Kuriyama H, Nishida M, Yamashita S, Okubo K, Matsubara K, Muraguchi M, Ohmoto Y, Funahashi T, Matsuzawa Y: Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999; 257: 79-83. (Pubitemid 29299050)
14. Ouchi N, Kihara S, Arita Y, Maeda K, Kuriyama H, Okamoto Y, Hotta K, Nishida M, Takahashi M, Nakamura T, Yamashita S, Funahashi T, Matsuzawa Y: Novel modulator for endothelial adhesion molecules: adipocyte derived plasma protein adiponectin. Circulation 1999; 100: 2473-2476. (Pubitemid 30005109)
15. Shin JY, Kim SY, Jeung MJ, Eun SH, Woo CW, Yoon SY, Lee KH: Serum adiponectin, C-reactive protein and TNF-alpha levels in obese Korean children. J Pediatr Endocrinol Metab 2008; 21: 23-29. (Pubitemid 351350839)
16. Alika?ifo?lu A, Gönç EN, Ozön ZA, Sen Y, Kandemir N: The relationship between serum adiponectin, tumor necrosis factor-alpha, leptin levels and insulin sensitivity in childhood and adolescent obesity: adiponectin is a marker of metabolic syndrome. J Clin Res Pediatr Endocrinol 2009; 1: 233-239.
17. Panagopoulou P, Galli-Tsinopoulou A, Fleva A, Pavlitou-Tsiontsi E, Vavatsi-Christaki N, Nousia-Arvanitakis S: Adiponectin and insulin resistance in childhood obesity. J Pediatr Gastroenterol Nutr 2008; 47: 356-362.
18. Koebnick C, Kelly LA, Lane CJ, Roberts CK, Shaibi GQ, Toledo-Corral CM, Davis JN, Weigensberg MJ, Goran MI: Combined association of maternal and paternal family history of diabetes with plasma leptin and adiponectin in overweight Hispanic children. Diabet Med 2008; 25: 1043-1048.
19. Matsuda M, DeFronzo RA: Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 1999; 22: 1462-1470. (Pubitemid 29418240)
20. Weyer C, Tataranni PA, Bogardus C, Pratley RE: Insulin resistance and insulin secretory dysfunction are independent predictors of worsening of glucose tolerance during each stage of type 2 diabetes development. Diabetes Care 2001; 24: 89-94.
21. Haffner SM, Miettinen H, Gaskill SP, Stern MP: Decreased insulin secretion and increased insulin resistance are independently related to the 7-year risk of NIDDM in Mexican-Americans. Diabetes 1995; 44: 1386-1391.
22. Lillioja S, Mott DM, Spraul M, Ferraro R, Foley JE, Ravussin E, Knowler WC, Bennett PH, Bogardus C: Insulin resistance and secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians. N Engl J Med 1993; 29: 1988-1992. (Pubitemid 24015042)
23. Martin BC, Warram JH, Krolewski AS, Bergman RN, Soeldner JS, Kahn CR: Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow up study. Lancet 1992; 340: 925-929.
24. Weyer C, Bogardus C, Mott DM, Pratley RE: The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest 1999; 104: 787-794. (Pubitemid 29536364)
25. Weyer C, Hanson RL, Tataranni PA, Bogardus C, Pratley RE: A high fasting plasma insulin concentration predicts type 2 diabetes independent of insulin resistance. Diabetes 2000; 49: 2094-2101.
26. Levy-Marchal C, Arslanian S, Cutfield W, Sinaiko A, Druet C, Marcovecchio ML, Chiarelli F, ESPE-LWPES-ISPAD-APPESAPEG-SLEP-JSPE: Insulin Resistance in Children Consensus Conference Group. Insulin resistance in children: consensus, perspective, and future directions. J Clin Endocrinol Metab 2010; 95: 5189-5198.
27. Arslanian SA, Bacha F, Saad R, Gungor N: Family history of type 2 diabetes is associated with decreased insulin sensitivity and an impaired balance between insulin sensitivity and insulin secretion in white youth. Diabetes Care 2005; 28: 115-119. (Pubitemid 40095792)
28. Danadian K, Balasekaran G, Lewy V, Meza MP, Robertson R, Arslanian SA: Insulin sensitivity in African-American children with and without family history of type 2 diabetes. Diabetes Care 1999; 22: 1325-1329. (Pubitemid 29350244)
29. Elbein SC, Hasstedt SJ, Wegner K, Kahn SE: Heritability of pancreatic-cell function among nondiabetic members of Caucasian familial type 2 diabetic kindreds. J Clin Endocrinol Metab 1999; 84: 1398-1403. (Pubitemid 30644406)
30. Liu BW, Lu Q, Ma CM, Wang SY, Lou DH, Lou XL, Yin FZ: Factors associated with insulin resistance and fasting plasma ghrelin levels in adolescents with obesity and family history of type 2 diabetes. Exp Clin Endocrinol Diabetes 2009; 117: 600-604.
31. Shimomura I, Funahashi T, Takahashi M, Maeda K, Kotani K, Nakamura T, Yamashita S, Miura M, Fukuda Y, Takemura K, Tokunaga K, Matsuzawa Y: Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity. Nat Med 1996; 2: 800-802.
32. Spiegelman BM, Flier JS: Adipogenesis and obesity: rounding out the big picture. Cell 1996; 87: 377-389. (Pubitemid 26374313)
33. Ouchi N, Kihara S, Arita Y, Okamoto Y, Maeda K, Kuriyama H, Hotta K, Nishida M, Takahashi M, Muraguchi M, Ohmoto Y, Nakamura T, Yamashita S, Funahashi T, Matsuzawa Y: Adiponectin, an adipocyte-derived plasma protein inhibits endothelial NF-kappa B signaling through a cAMP-dependent pathway. Circulation 2000; 102: 1296-1301.
34. Lihn AS, Østergard T, Nyholm B, Pedersen SB, Richelsen B, Schmitz O: Adiponectin expression in adipose tissue is reduced in firstdegree relatives of type 2 diabetic patients. Am J Physiol Endocrinol Metab 2003; 284:E443-E448. (Pubitemid 36120119)
35. Daimon M, Oizumi T, Saitoh T, Kameda W, Hirata A, Yamaguchi H, Ohnuma H, Igarashi M, Tominaga M, Kato T: Decreased serum levels of adiponectin are a risk factor for the progression to type 2 diabetes in the Japanese population: the Funagata study. Diabetes Care 2003; 26: 2015-2020. (Pubitemid 41184244)
36. Cnop M, Havel PJ, Utzschneider KM, Carr DB, Sinha MK, Boyko EJ, Retzlaff BM, Knopp RH, Brunzell JD, Kahn SE: Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia 2003; 46: 459-469. (Pubitemid 36577787)
37. Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, Iwahashi H, Kuriyama H, Ouchi N, Maeda K, Nishida M, Kihara S, Sakai N, Nakajima T, Hasegawa K, Muraguchi M, Ohmoto Y, Nakamura T, Yamashita S, Hanafusa T, Matsuzawa Y: Plasma concentrations of novel, adiposespecific protein, adiponectin in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 2000; 20: 1595-1599. (Pubitemid 30353893)
38. Chu NF, Shen MH, Wu DM, Lai CJ: Relationship between plasma adiponectin levels and metabolic risk profiles in Taiwanese children. Obes Res 2005; 13: 2014-2020.